ABSTRACTS

O.1 ABVD (8 cycles) vs. BEACOPP (4 escalated cycles => 4 baseline) in stage III – IV low risk Hodgkin Lymphoma (IPS 0–2): final results of LYSA H34 trial

BJH - volume 5, issue Abstract Book BHS, january 2014

M. André MD, PhD, B. De Prijck MD, A. Kentos MD, PhD, A. Van Hoof MD, PhD, C. Bonnet MD, A. Sonet MD, M. Maerevoet MD, E. Van den Neste MD, PhD, A. Bosly MD, PhD, N. Mounier

Read more

O.2 Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation

BJH - volume 5, issue Abstract Book BHS, january 2014

M. Binsfeld , Y. Beguin MD, PhD, L. Belle , E. Otjacques , M. Hannon , A. Briquet PhD, P. Drion , B. Bogen , prof. F. Baron , J. Caers MD, PhD

Read more

O.3 Comparison of 2 nonmyeloablative regimens for allogeneic HCT: a phase II randomized study from the HCT committee of the BHS

BJH - volume 5, issue Abstract Book BHS, january 2014

prof. F. Baron , P. Zachée MD, PhD, J. Maertens MD, PhD, T. Kerre MD, PhD, A. Ory , L. Seidel , C. Graux MD, PhD, P. Lewalle MD, PhD, H. Schouten , K. Theunissen MD, R. Schots MD, PhD, Y. Beguin MD, PhD

Read more

O.4 Functional characterization of activating mutants of the JAK3 tyrosine kinase implicated in tumoral transformation of T lymphocytes

BJH - volume 5, issue Abstract Book BHS, january 2014

E. Losdyck , L. Springuel , T. Hornakova , J.C. Renauld , L. Knoops MD, PhD

Read more

O.5 In vivo gene expression profiling in the murine 5T33MM model identifies epigenetic-regulated genes predictive for prognosis and drug-sensitivity

BJH - volume 5, issue Abstract Book BHS, january 2014

dr. K. Maes , E. De Smedt , D. Hose , E. Van Valckenborgh PhD, E. Menu , B. Klein , K. Vanderkerken PhD, J. Moreaux , E. De Bruyne

Read more

O.6 Long-term survival in patients receiving rhEPO following allogeneic hematopoietic cell transplantation

BJH - volume 5, issue Abstract Book BHS, january 2014

A. Jaspers MD, PhD, prof. F. Baron , E. Willems MD, PhD, K. Hafraoui , C. Bonnet MD, Y. Beguin MD, PhD

Read more